Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionBedel Financial Consulting, Inc.
Latest Disclosed Ownership5,800 shares
Latest Disclosed Value $ 351,752
Bedel Financial Consulting, Inc. reports 0.17% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 4, 2026 - Bedel Financial Consulting, Inc. filed a 13F-HR form disclosing ownership of 5,800 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $304,036 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 5,790 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.17% during the quarter. The current value of the position is $275,094 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,800 10 0.17 352 12.50 0.0391
2026-01-28 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,790 -52 -0.89 312 18.63 0.0336
2025-11-07 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,842 12 0.21 263 -2.23 0.0336
2025-08-12 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,830 -31 -0.53 270 -3.24 0.0368
2025-05-07 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,861 171 3.01 279 -17.99 0.0399
2025-02-06 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,690 175 3.17 340 18.95 0.0472
2024-11-12 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,515 462 9.14 285 36.36 0.0403
2024-08-05 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,053 -828 -14.08 210 -34.28 0.0308
2024-05-07 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,881 10 0.17 319 5.65 0.0500
2024-02-13 2023-12-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 5,871 9 0.15 301 -11.47 0.0552
2024-02-08 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,871 9 301 0.0552
2024-02-08 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,862 7 0.12 340 -9.09 0.0689
2023-08-10 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,855 1,595 37.44 374 26.78 0.0782
2023-05-02 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,260 -1,594 -27.23 295 -29.93 0.0719
2023-02-07 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,854 0 0.00 421 -9.27 0.1047
2022-11-08 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,854 -240 -3.94 464 -1.07 0.1230
2022-08-04 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,094 -178 -2.84 469 2.40 0.1372
2022-04-19 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,272 -46 -0.73 458 16.24 0.1439
2022-01-11 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,318 -283 -4.29 394 0.77 0.1225
2021-10-12 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,601 5 0.08 391 -11.34 0.1342
2021-08-03 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,596 506 8.31 441 14.84 0.1535
2021-04-26 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,090 1,006 19.79 384 21.90 0.1485
2021-02-02 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,084 -54 -1.05 315 1.61 0.1398
2020-10-20 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,138 5 0.10 310 2.65 0.1550
2020-07-14 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 5,133 0 0.00 302 5.59 0.1628
2020-05-06 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 5,133 -390 -7.06 286 -19.21 0.1891
2020-01-28 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 5,523 186 3.49 354 30.63 0.2007
2019-10-09 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 5,337 -894 -14.35 271 -4.24 0.1631
2019-08-01 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 6,231 5 0.08 283 -4.71 0.1720
2019-05-02 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 6,226 1,005 19.25 297 9.59 0.1894
2019-01-28 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 5,221 -4,588 -46.77 271 -52.20 0.1950
2018-11-01 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 9,809 389 4.13 567 8.83 0.3784
2018-07-18 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 9,420 4 0.04 521 -12.58 0.3832
2018-05-03 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,416 4 0.04 596 3.29 0.4530
2018-02-06 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,412 9,412 577 0.5192
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.